MacroGenics, Inc.
MGNX
$1.81
$0.137.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -639.30% | -295.96% | -1,930.74% | 74.55% | 92.44% |
| Total Depreciation and Amortization | -21.82% | -32.70% | -36.80% | -28.76% | -18.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.17% | 116.24% | 57.97% | -585.78% | -588.13% |
| Change in Net Operating Assets | -97.39% | -75.12% | -88.64% | 274.32% | 969.76% |
| Cash from Operations | 12.57% | -178.22% | -3,183.02% | -163.72% | 10.07% |
| Capital Expenditure | -110.09% | -141.12% | -96.15% | -11.57% | 51.31% |
| Sale of Property, Plant, and Equipment | 150.00% | 150.00% | 66.67% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 294.99% | 221.89% | 564.88% | -167.23% | -205.44% |
| Cash from Investing | 286.43% | 217.61% | 503.31% | -171.09% | -213.25% |
| Total Debt Issued | -- | -- | -- | -200.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 193.84% | 57.50% | 62.27% | 41.21% | -30.13% |
| Repurchase of Common Stock | -708.82% | -707.52% | -1,317.88% | -1,376.16% | -2,085.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -49.75% | -- | -- |
| Cash from Financing | -99.36% | -99.29% | -49.72% | -50.37% | 8,963.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,132.85% | 1,419.51% | -128.44% | -181.33% | 45.64% |